Myriad Genetics Inc. (MYGN)
Myriad Genetics Max Pain By Strike
MYGN trades at $6.91, 15.2% above the near-term max pain of $6 expiring Sep 19, 2025 (11 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is rising across expirations ($4-$6), reflecting growing call interest at higher strikes. Key magnetic zone at 4 where 3 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
Myriad Genetics Max Pain By Expiry
Max pain for MYGN shows an upward trend from 4 to 6, suggesting bullish positioning in longer-dated options. The 43% spread signals divergent expectations across timeframes. Most levels below 6.91 may cap rallies. Strong magnetic level at 4 (3 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Sep 19, 2025 | 6 | -0.91 (-13.17%) |
| Oct 17, 2025 | 4 | -2.91 (-42.11%) |
| Nov 21, 2025 | 4 | -2.91 (-42.11%) |
| Jan 16, 2026 | 5 | -1.91 (-27.64%) |
| Feb 20, 2026 | 4 | -2.91 (-42.11%) |